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Abstract 
Population growth, increasing affluence, and greater access to medicines have led to an 
increase in active pharmaceutical ingredients (APIs) entering sewerage networks. In areas 
with high wastewater reuse, residual quantities of APIs may enter soils via irrigation with 
treated, partially treated, or untreated wastewater and sludge. Wastewater used for irrigation 
is currently not included in chemical environmental risk assessments and requires further 
consideration in areas with high water reuse. This study critically assesses the contemporary 
understanding of the occurrence and fate of APIs in soils of low and lower-middle income 
countries (LLMIC), to identify gaps in knowledge that addressing would contribute to the 
development of risk assessments in LLMIC. The physico-chemical properties of APIs and 
soils vary greatly globally, impacting on API fate, bioaccumulation and toxicity. The impact 
of pH, clay and organic matter on the fate of organic ionisable compounds are discussed in 
detail. This study identifies the occurrence and the partitioning and degradation coefficients 
for APIs in soil:porewater systems, API usage data in LLMICS and removal rates (where 
used) within sewage treatment plants as key areas where data are missing in order to inform 
robust environmental risk assessment methodologies.  
Keywords: Pharmaceuticals; Soil; Lower and lower middle income countries; Terrestrial risk 
Assessment; Wastewater; irrigation  
1. Introduction 
There has been a global increase in the use of active pharmaceutical ingredients 
(APIs)
1
 in recent decades due to population growth, increasing affluence, changes in disease 
burdens and easier access to medication. In the low and lower-middle income countries 
(LLMIC) of Asia, Africa and Central and South America, the use of human pharmaceuticals 
increased by 23-29 % between 2000 and 2011 (WHO 2011). As a consequence, the loadings 
of residual APIs and other down the drain chemicals (including personal care products) to 
soils, surface and ground waters of these countries will increase. The major vector of this 
loading is wastewater (Corcoran et al. 2010; WHO 2006b, c, d). Wastewater is defined as a 
combination of one or more of blackwater (excreta, urine, faecal sludge), greywater (kitchen 
and bathing wastewater), commercial and industrial effluent (including hospitals), stormwater 
and other urban run-off, and agricultural, horticultural and aquacultural effluent. Each may be 
treated, partially treated or untreated (Corcoran et al. 2010; Jiménez et al. 2010). Difficulties 
in quantifying the magnitude of wastewater loads, in tandem with a paucity of environmental 
monitoring data of APIs in LLMIC, makes accurate and precise predictions of temporal 
trends in API loadings uncertain (Jiménez et al. 2010; Kookana et al. 2014). 
Many LLMIC are experiencing physical or economic water scarcity (Fig. 1) with the 
former particularly important in northern and southern Africa and southern Asia. To counter-
act shortages of good quality water in arid and semi-arid regions and to conserve its use, 
many LLMIC use the wastewater they generate for irrigation of agricultural and horticultural 
land. The water stressed areas of southern Asia produce wastewater in excess of 10 x 10
9
 m
3
 
yr
-1
 (Fig. S1) with up to 20 % being used for irrigation. Other countries such as Israel, Jordan, 
Syria, Iraq and Mexico use more than 40 % of their municipal wastewater for this purpose 
(Fig. 2(a)). Globally, about 20 million ha of agricultural land is irrigated with wastewater 
(Scott et al. 2004), with the highest proportions of cultivated areas equipped for irrigation 
found in the Middle East, southern Asia and western South America, as shown in Fig. 2(b). 
Per capita daily food consumption requires 2 – 5 m3 of water (Corcoran et al. 2010), making 
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agriculture a significant requirement for water, particularly in the extensively irrigated 
regions noted above (Fig. S2). Irrigation is dominated by untreated and untreated-diluted 
wastewater, notably in China (> 3.6 million ha), India (> 1 million ha) and Mexico (ca. 
190,000 ha), while treated water is extensively used in Chile, Mexico and Egypt (238, 000 ha) 
(Lautze et al. 2014). Across a range of LLMIC, 80 % of cities use mainly untreated and 
untreated-diluted wastewater for irrigation (Jiménez et al. 2010). In arid areas, cities such as 
Dakar (Senegal), Accra (Ghana) and Tamale (Ghana) produce 60-100 % of the consumed 
leafy vegetables within the city using wastewater irrigation, while 60-80 % of the perishable 
food for local markets in Hanoi (Vietnam) is produced using diluted wastewater (Corcoran et 
al. 2010; Drechsel et al. 2006). Water shortages are predicted to become more widespread 
and acute as human populations increase in number and urbanisation and industrialisation 
expand, food consumption patterns change, and rainfall distribution and volume alter as a 
result of climate change (Corcoran et al. 2010; Hanjra and Qureshi 2010). Nevertheless, there 
appears to be the potential to markedly increase the recovery and re-use of wastewater in 
many LLMIC, particularly for agricultural use close to highly urbanised areas, given the 
appropriate incentives (Jiménez et al. 2010; Lautze et al. 2014; WHO 2006c, d). 
 
 
Fig. 1. Regions of physical and economic water scarcity (International Water 
Management Institute 2006) 
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Fig. 2. Global water statistics. (a) Municipal wastewater used for irrigation (%), (b) 
Cultivated area equipped for irrigation (%). (FAO 2015). 
 
  
There is currently a lack of public usage data for the amount and type of APIs used in 
many LLMIC due to poor record keeping, extensive self-medication and the use of non-
prescribed APIs over large population numbers (Kookana et al. 2014; Kotwani et al. 2012; 
Rehman et al. 2013). This knowledge gap is further confounded by inconsistent adherence to 
therapeutic treatments, particularly for longer-term prescribing (Kookana et al. 2014). For 
some groups of APIs, per capita use may be similar between LLMIC and higher income 
countries, but owing to larger populations in LLMIC (40 % of the global human population 
live in China, India, Bangladesh and Pakistan; Rehman et al. 2013) the actual tonnage used is 
much greater (Kookana et al. 2014). Usage data are often commercially sensitive and thus 
unavailable to the wider scientific community; however, projected spending patterns indicate 
continued expansion of API use in LLMIC (Fig. S3). In addition, there has been a marked 
relocation of pharmaceutical manufacturing from high income countries to LLMIC in recent 
years, with an annual growth of 10 – 15 %, resulting in ca. 13,000 industrial production units 
in India and China alone (Cardoso et al. 2014; Rehman et al. 2013). The effluents from these 
generally poorly regulated sites have been identified as a significant source of APIs to 
adjacent surface waters and sewage treatment works (Larsson 2014; Liu and Wong 2013; 
Rehman et al. 2013). This can lead to localised ‘hot spots’ which are manageable if, inter alia, 
site emissions of APIs are known and safe discharge standards or environmental reference 
concentrations are developed and enforced (Murray-Smith et al. 2012); nevertheless, there 
appear to be little data on effluent API loadings (Cardoso et al. 2014). Thus, it is clear that the 
paucity of data on API environmental loading from consumption and manufacture is a 
significant obstacle to the wider understanding of API occurrence, fate and impacts in 
LLMIC. Concerns regarding persistence and antimicrobial resistance of APIs were 
highlighted as a priority issue in October 2015 at the International Conference on Chemicals 
Management led by the United Nations Environment Programme, which called for increased 
global knowledge of pharmaceuticals in all environmental compartments (Nature 2015). This 
conference backed the need for global cooperation and awareness to overcome the obstacle of 
the understanding of APIs occurrence and fate in LLMIC.  
Guidelines on the safe use of wastewater in LLMIC have been produced since the 
1970s, with the most recent published in 2006 (WHO 2006a, b, c, d). The Guidelines are a 
flexible management framework for safeguarding human health while maximising the 
benefits of wastewater use in agriculture and aquaculture. The constituents of wastewater 
addressed with respect to safety in the Guidelines include pathogens, salts, metals, nutrients, 
acids and bases, suspended matter, organic matter and toxic organic compounds. The last 
class includes APIs (WHO 2006b, c), but given that the concern regarding these compounds 
is recent, regulatory frameworks for controlling API loadings (or indeed, other organic 
contaminants) to soils and waters are rare in LLMIC (Jiménez et al. 2010; Kookana et al. 
2014; Sorensen et al. 2015). Indeed, it is only since 2006 that a comprehensive environmental 
risk assessment has been required for all new marketing authorisation applications for human 
medicinal products in the European Union (EMEA, 2006 – now EMA). The underlying 
assumption for risk assessments is that wastewater is universally treated in sewage treatment 
plants (as required under EU law), which, as has been described, does not hold for LLMIC. 
Furthermore, the European environmental risk assessment framework is only concerned with 
exposure to API following application of sewage biosolids to soil, and does not include 
additional scenarios, such as irrigation with wastewater and other contaminated water sources 
which are relevant to LLMIC. Nevertheless, the environmental risk assessment approach 
would provide a good framework for LLMIC to adopt, including both Phase I and Phase II 
(Tier A and B assessments). Clearly, the action limits used in Europe (EMEA 2006) for 
triggering more extensive terrestrial risk assessment by regulators within LLMIC would need 
to be critically examined to take account of local circumstances. For example, API use and 
disposal, chemical characteristics and speciation, water re-use, soil physico-chemistry and 
biology, and climate. It is noteworthy that the appropriateness of some of the action limits in 
the development of more robust terrestrial risk assessments for APIs in the EU are also under 
scrutiny, primarily because APIs can exist either as cations, anions or zwitterions within the 
pH range covering most surface waters (ECETOC 2013a). 
The aims of this study are to critically assess contemporary understanding of the 
occurrence of APIs in soils of LLMIC, to identify API sources to soils, to develop a global 
overview of key abiotic soil characteristics expected to influence the fate of soil-associated 
APIs, and highlight the datasets required for the development of a more globally relevant 
approach to environmental risk assessments that capture exposure scenarios in LLMIC.  
2. APIs in LLMIC soils: occurrence, sources and factors controlling their fate 
The occurrence, sources and fate of APIs in soils following applications of 
wastewater and biosolids has been an area of concern and study for at least a decade, but the 
main focus has been on the high income countries of North America and Europe and 
antibiotic resistance of soil microbes (BIO Intelligence Service 2013; Kinney et al. 2006; 
Thiele-Bruhn 2003). Similar studies in LLMIC, with the general exception of China, are 
much rarer (Kookana et al. 2014; Liu and Wong 2013; Rehman et al. 2013). 
 
2.1 Occurrence in soils 
Concentration data for APIs in LLMIC soils are sparse, as shown in Table 1. The 
majority of APIs identified in studies undertaken were veterinary and human antibiotics (e.g. 
oxytetracycline, sulfamerazine, norfloxacin), as a result of the combination of high usage in 
human and animal medicine and concerns about antimicrobial resistance (Chen et al. 2011; 
Gibson et al. 2010; Li et al. 2011; Rutgersson et al. 2014). Notably, data are missing for 
LLMIC hosting extensive API manufacturing, including Bangladesh and Pakistan, with only 
a single dataset available for India. In arid climates, wastewater for irrigation is added 
continuously throughout the year, which, in principle, can lead to accumulation of API in the 
soil and leaching of APIs through soil profiles to groundwater even for readily biodegradable 
compounds. In soils irrigated with untreated wastewater in the Tula Valley (Mexico), Gibson 
et al. (2010) calculated that carbamazepine and triclosan had accumulated in upper soils 
horizons by a factor of 603-942 % and 519-858 % respectively. The concentration patterns of 
both compounds were highly and positively correlated with the soil organic matter 
concentration, suggesting that this soil component was a critical factor in their accumulation. 
For other APIs studied (ibuprofen, naproxen and diclofenac) there was no evidence of 
accumulation, probably due to biodegradation rates exceeding application rates.  
  
Table 1.  Concentrations (µg kg
-1
 dry weight) of APIs in soils of low and lower-middle  
income countries. 
Location API Concentration  
(µg kg
-1
) 
Reference  
Pearl River Delta 
(China) 
Oxytetracycline 
Sulfamerazine 
Norfloxacin 
9.6 ± 22.9 
16.0 ± 20.4 
61.9 ± 33.1 
(Li et al. 2011) 
Hebei (China) Salicylic acid  
Oxytetracycline 
Tetracycline  
4.5 ± 0.8 
6.2 ± 0.2 
6.9 ± 0.5 
(Chen et al. 2011) 
Tula Valley 
(Mexico) 
Ibuprofen 
Naproxen 
Carbamazepine  
Triclosan 
Diclofenac 
< 0.1 – 0.30 
< 0.20 – 2.40 
0.1 – 16.4 
0.4 – 35.5 
< 1.0 
(Gibson et al. 2010)
a
 
Baithole (India) Ciprofloxacin 
Norfloxacin 
Ofloxacin 
0.014 
0.011 
0.019 
(Rutgersson et al. 
2014) 
a
 Concentration range reflects 5 soils and variable sampling depths 
 
2.2 Wastewater application to soils 
In many LLMIC the proportion of the population living in an urban environment is 
smaller than in high income countries and sewerage connectivity is much lower (Kookana et 
al. 2014). In addition, sewage treatment plants often underperform or are underused. Little of 
the non-urban population is connected to sewerage systems, instead relying on septic tanks, 
pit latrines and other low technology systems. As a consequence, in LLMIC, as a whole, ca. 
90 % of untreated and poorly treated wastewater is discharged directly to surface water and 
soils (Fig. 3) (Kookana et al. 2014; Sorensen et al. 2015; UN Water 2008). The surface water 
contaminated with wastewater may be subsequently used for irrigation. 
 
  
Fig. 3.  Potential flows of APIs in the environment from their sources in the industry, 
domestic and agricultural sectors. Dotted lines indicate less important pathways 
in LLMICs, shaded areas represent flows discussed in the text (Kookana et al. 
2014; Sorensen et al. 2015; UN Water 2008).  
 
Removal efficiencies of APIs in LLMIC  sewage treatment plants  depend on its 
concentration in the influent, its physico-chemical properties, the method of treatment and the 
operating conditions (hydraulic/sludge residence times and the weather/climate during 
processing). Variation in removal efficiencies can also be the result of experimental factors 
that need to be assessed before using data for risk assessments or modelling. These include 
type of sampling (e.g. grab samples or composite sampling schemes) and the inclusion of 
hydraulic retention times when sampling.  
The most commonly reported treatment type is activated sludge as it is one of the 
most commonly used treatment type used globally (Melvin & Leusch 2016). In Bangkok 
(Thailand), sewage treatment plants with different activated sludge treatment processes 
achieved a wide range of API removal efficiencies, from 19-90 % (grab samples). For 
example, diclofenac showed variable removal (19-60 %) while atenolol removal was higher 
(76-90%) and more consistent (Tewari et al. 2013). This variation is not confined to LLMIC 
countries; in European Union countries, 0-98 % removal of APIs has been measured 
(Castiglioni et al. 2005; Gardner et al. 2013). Seasonal differences in API concentrations in 
the receiving waters were found between the high flow in January (1-148 ng L
-1
) and low 
flow in September (<1-1100 ng L
-1
) owing to dilution, indicating that climactic variations 
must also be taken into account when assessing the efficiency of sewage treatment plants and 
dilution in the receiving environment (Tewari et al. 2013). Korean sewage treatment plants 
showed a similar variation in API removal efficiencies, with a wide range for carbamazepine 
removal (42-83%) and a narrow one for naproxen (72-88%) (grab samples) (Sim et al. 2010).  
Treatment types commonly used in rural areas globally include lagoons and oxidation ditches 
(Melvin & Leusch 2016). In rural Australian communities using a series of 10 lagoons for 
sewage treatment, high removal efficiencies were measured for naproxen (90%) and 
diclofenac (90%) (composite sampling scheme) (Ying et al 2009). In this study degradation 
of the APIs was suggested to be the primary removal mechanism due to long residence times 
and the removal of sludge and solid sedimentation in the early stage lagoons. Whilst 
Australia is not a LLMIC, sewage processing in rural communities is relevant due to the arid 
climate and simple sewage infrastructure. It can be concluded that further studies into global 
removal efficiencies for a wider range of APIs and treatment processes are required. 
Concentrations of APIs in effluents from the pharmaceutical industry in LLMIC can 
be a significant source of APIs if discharges are poorly managed, as API levels in the effluent 
can be orders of magnitude higher than those in urban sewage effluent (Cardoso et al. 2014; 
Larsson 2014). In China and Korea, industrial wastewater is often mixed with domestic 
wastewater prior to discharge to the sewage treatment plant in order to enhance 
biodegradation of organic contaminants, while in India, Pakistan and Bangladesh, industrial 
wastewater is more often discharged directly into surface waters (rivers) or domestic sewage 
systems where these exist (Rehman et al. 2015). Despite the potential for ecotoxicological 
impacts, there appear to be few data on industrial effluent API loadings in LLMIC (Larsson 
2014). 
 
2.3 Physico-chemical factors controlling the fate of APIs in soil 
The fate and toxicity of ionisable organic contaminants in soils is significantly 
influenced by soil pH, the concentration and type of organic matter and clay (and hence ion 
exchange capacity), the lipophilicity of the API (described by the n-octanol-water partition 
coefficient (Kow), and its strength as an acid or base (described by the acid dissociation 
constant, Ka). Nevertheless, other factors, such as soil aeration, moisture content, temperature 
and patterns of API use, form emitted and mode of emission (episodic or continuous) will 
also play a role (Dalkmann et al. 2014; Jjemba 2006). For APIs, of which > 80% are 
ionisable at environmental pH (5-9), predicting how changes in the soil environment 
influence the ionisation of the molecule and its resulting lipophilicity and hence its behaviour 
and fate (accumulation, abiotic and biotic degradation, leaching), is an area of ongoing 
research with respect to exposure assessment and environmental risk assessment (Boxall et al. 
2012; ECETOC 2013a). The ambient conditions of soils will vary with location and climate, 
which makes the direct knowledge transfer of API behaviour and fate in soils in high income 
countries, where most studies have been undertaken, to LLMIC less straightforward than 
perhaps anticipated. In the following sections, API – soil particle interactions and the 
potential roles of soil pH, clay and organic matter in relation to API fate in wastewater used 
for irrigation by LLMIC are examined in more detail.  
 
2.3.1 API – soil particle interactions 
The range of physico-chemical interactions that may occur between an API and soil 
particles are summarised in Figure 4 for propanolol. This API has a pKa of 9.45 so at pH 7 
the cation will be 282 times more abundant than the neutral form of the molecule. The extent 
of ionisation and the charge on the ionised molecule will affect the extent to which these 
reactions occur. In reaction 1, the protonated propranolol molecule forms an ionic bond with 
a negatively charged surface group on the particle. With reaction 2, a free (i.e. unprotonated) 
molecule reacts with a functional group on the particle to form a covalent bond. For reaction 
3, the naphthoxy side chain of propranolol undergoes hydrophobic interactions with 
particulate organic matter (POM), or the cation can bond with negatively charged functional 
groups within the POM. For the final reaction, 4, van der Waals forces and dipole–dipole 
interactions may be involved in sorption. Other processes which may influence interactions 
of APIs with particles include ligand exchange and hydrogen bonding (ECETOC 2013b). In 
contrast to propanolol, naproxen (pKa 4.15) ionises to an anion and at pH 7 the anion will be 
708 times more abundant than the neutral molecule; interactions with anionic surface 
exchange sites would therefore be negligible but it may form a hemi-acetal through carbonyl 
addition to the reactive surface group. 
 Fig. 4. An example of the possible sorptive interactions between the API propranolol 
and a heterogeneous soil particle that may control partitioning of the molecule 
between the dissolved and particulate phases in soils (adapted from 
Schwarzenbach et al. 1993).  
 
2.3.2 Soil pH 
The total potential acidity of a soil essentially comprises the activity of protons in soil 
pore water plus exchangeable protons at the surfaces of the soil particles (Kah and Brown, 
2007). Fig. 5 shows the global distributions of soil pH, determined in a water/soil suspension 
(FAO/IIASA/ISRIC/ISS-CAS/JRC 2009). While the water method for pH measurement will 
not necessarily account for exchangeable protons (Kah and Brown 2007), top soils (0-30 cm) 
in LLMIC using wastewater irrigation (shown in Fig. 2(a)) generally fall into the pH range 
5.5-8.5, with soils in southern China, eastern India, and Bangladesh more frequently in the 
range 4.5–5.5. Wastewater is usually slightly alkaline, which will mitigate the generally 
acidic nature of the soil environment to some extent (WHO 2006b).  
Soil pH will influence the net charge on ionisable APIs and they will be fully ionised (> 
99 %) when the pH is at ± 2 pH units from their log Ka (pKa) values, as shown in Fig. S4; 
thus many APIs will be significantly ionised at typical soil pH. APIs with more than one pKa 
value will exhibit additional charge complexity.  
Ionic APIs will be less lipophilic than the neutral forms and hence more water soluble; 
nevertheless, cationic (basic) APIs may be expected to sorb to negatively charged 
components within the soil, such as clay and organic matter (Franco et al. 2009; 
Lertpaitoonpan et al. 2009).  With reference to Fig. 4, propranolol (pKa 9.3) will be cationic 
at most soil pH, and is expected to sorb to the negatively charged components of soils via 
electrostatic attraction (ter Laak et al. 2006; Schaffer et al., 2012). In contrast, acidic APIs, 
such as naproxen (pKa 4.2), will be in anionic form at soil pH higher than the pKa; thus a 
reduction in electrostatic sorption at > pH 5 may be the result of repulsion between the 
anionic API and the negative charge on the soil (Paul et al 2013). Fluoroquinolone antibiotics 
have two pKa values (e.g. ofloxacin, pKa 5.97 and 8.28) which at environmental pH tend to 
be zwitterionic, but can also be cationic, anionic, or uncharged (Vazquez-Roig et al 2012). At 
pH ≤ 5 ciprofloxacin (pKa 6.18 and 8.76) electrostatic sorption can be hypothesized to 
increase as pH decreases due to the  cationic form of the API interacting with the negatively 
charged soil surfaces. At pH ≥ 5, ciprofloxacin sorption will decrease due to diminishing  
cationic charge and an increase in the anionic carboxylic acid moiety within the net neutral 
zwitterion, leading to repulsion from  the negatively charged soil components (Vasudevan et 
al 2009). 
The more acid soils found in parts of Asia, noted above, are relatively rich in 
positively charged Al and Fe sesquioxides (FAO 2014) which may provide sorption sites for 
anionic (acidic) APIs (Hyun and Lee 2004; White 2013). Soil pH will also influence the pH-
dependent charge on the organic matter, clay minerals and metal sesquioxide components of 
the soil, which in turn might be expected to influence API sorption (Hyun and Lee 2004). 
 
 
 
Fig. 5.  Global distribution of soil pH (0-30 cm depth) (FAO/IIASA/ISRIC/ISS-
CAS/JRC 2009). Coverage in red indicates no data. 
 
2.3.3 Soil clays 
Clays are essentially aluminosilicate minerals with a particle size of less than 2 µm. 
Fig. 6(a) shows the distribution of the clay content in surface soils (defined as 0-30 cm depth) 
across the globe (FAO/IIASA/ISRIC/ISS-CAS/JRC 2009). The LLMIC that use wastewater 
for irrigation, as shown in Fig. 2(a), have soils with a wide range of clay content. In China, 
the southeastern regions have contents of 30-45 %, falling to mainly 15-30 % in the north, 
while soils with < 15 % clay are more frequent in the western areas. Soils in the central 
region of India have high clay contents (45-60 %), with some in the 30-45 % range. In the 
coastal zones of India, in Bangladesh and in parts of Pakistan, 15-30 % clay is more common. 
Lower clay contents (< 15 %) are found in northern India and central Pakistan. In north 
Africa, soils with clay contents 15-30 % are common, falling to < 15 % in the eastern areas. 
Soils along the western coastal zone of South America have clay contents in the range 15-
30 %. Elsewhere in the sub-continent and also in Mexico, soils with a wide range of clay 
content occur.   
  
 (a) 
 
(b) 
 
Fig. 6.  Global distribution of the (a) clay content (% weight) and (b) clay cation 
exchange capacity (CEC; cmol
-1
 kg clay) in the top 30 cm of soil 
(FAO/IIASA/ISRIC/ISS-CAS/JRC 2009).  
 
 Clays generally have a cation exchange capacity (CEC) at pH values found in 
terrestrial systems because of isomorphous substitution (i.e. the replacement in the mineral 
structure of one cation with another of a different charge) and de-protonation of surface 
hydroxyl groups (the extent dependent on pore water pH) while the overall magnitude of the 
CEC value will depend on the type of clay. The higher the CEC value the more sorption sites 
are potentially available. The distribution of the clay CEC in surface soils across the globe 
varies considerably (Fig. 6(b)) (FAO/IIASA/ISRIC/ISS-CAS/JRC 2009). Clay CEC values 
are generally in the range 22-55 cmol
-1
 kg clay (at pH 7) across many of the LLMIC of 
interest. Values are lower in southeastern China and central South America (< 22 cmol
-1
 kg 
clay, and often < 10 cmol
-1
 kg clay), and higher in areas of north and western China, central 
India, the coastal zones of north Africa and western South America. Clays in Mexican soils 
have some of the highest values (> 104 cmol
-1
 kg clay) observed. In relatively acidic 
environments however, clays may exhibit an anion exchange capacity (AEC) because of 
protonation of the surface hydroxyl groups. The AEC:CEC ratio will reflect the difference 
between the soil pore water pH and the pH of the net zero charge of the particular clay type 
(Hyun and Lee 2004). Thus, ionic sorption of an API to the clay will be a function of the 
AEC:CEC ratio, soil solution pH and API pKa. Clay CEC has been reported to be important 
for the sorption of some antibiotic APIs (Vasudevan et al. 2009; Yan et al. 2012). 
 
2.3.4 Soil organic matter 
Soil organic matter , which represents the variable decomposition products of 
autochthonous and allochthonous inputs of organic matter (animal, plant, microbial biomass) 
to soils, is comprised of particulate organic matter (POM) and, in pore water, colloidal 
dissolved organic matter (CDOM). Fig. 7(a) shows the global distribution of POM, as organic 
carbon, in surface soils (FAO/IIASA/ISRIC/ISS-CAS/JRC 2009) and most LLMIC that use 
wastewater for irrigation (Fig. 2a), have soils with organic carbon concentrations above 0.6 % 
(w/w), indicating fertile soils with, in principle, good contaminant sorption properties. In 
contrast, soils in northern China, Pakistan and much of North Africa are low in organic 
carbon (< 0.6 % w/w) and probably need fertiliser to be productive, so wastewater irrigation 
would likely enhance the organic carbon content of these soils (Qadir et al. 2010). 
  
 (a) 
 
(b)  
 
Fig. 7. Global distribution of the (a) organic carbon (% weight) and (b) soil cation 
exchange capacity (CEC; cmol
-1
 kg soil) in the top 30 cm of soil 
(FAO/IIASA/ISRIC/ISS-CAS/JRC 2009). Coverage in red indicates no data. 
  
 Important fractions of soil POM occur as polymeric macro-molecules with relatively 
high aromatic and alkyl content (Kleber et al. 2007). Partitioning of hydrophobic 
contaminants into this fraction has historically been quantified empirically by the organic 
carbon–water partition coefficient, Koc (ECETOC 2013a), and APIs with aromatic 
constituents and/or high carbon fraction may partition into the hydrophobic POM fraction and 
contribute to the API Koc value. A range of APIs (carbamazepine, ibuprofen, naproxen and 
diclofenac, for example) were generally better retained in soils with relatively high POM and 
their concentrations were positively correlated with POM concentrations (Chefetz et al. 2008; 
Drillia et al. 2005; Gibson et al. 2010; Xu et al. 2009). In contrast, partitioning into soil solids 
of these APIs was less extensive in low POM soils because of reduced hydrophobic 
interactions with the POM and probable binding of API with CDOM in some cases.  
POM also has a CEC because of a pH-dependent net negative surface charge. CEC 
values of 60 - 300 cmol kg
–1
 organic carbon (at pH 7) may account for 25 - 90% of the total 
CEC of soils, and in some cases may be more important than clays. Thus transfer of the 
neutral and cationic forms of all but the most water-soluble APIs from solution to POM will 
occur (Kinney et al. 2006; Gibson et al. 2010) and it can be concluded that the Koc value will 
comprise both a hydrophobic and a hydrophilic component. Fig. 7(b) shows the global 
distribution of top soil CEC due to both organic matter and clay (FAO/IIASA/ISRIC/ISS-
CAS/JRC 2009). Soils with CEC values below 10 cmol
-1
 kg soil are considered poor at cation 
retention, and these occur in southeastern, northern and western China, coastal regions of 
India, confined areas of North Africa and much of South America. Elsewhere, intermediate 
(22-55 cmol
-1
 kg soil) values of CEC dominate, with highest values found in parts of central 
India and throughout Mexico. 
In both high and low POM soils, the transport of APIs may be enhanced by irrigation 
with treated and untreated wastewater (Drillia et al. 2005; Gibson et al. 2010). Thus, the 
formation of API–CDOM complexes, as discussed below, may contribute to enhanced API 
solubility and mobility if the CDOM is not surface reactive, but API mobility may decrease if 
surface sorption occurs (Blackwell et al. 2009; Chefetz et al. 2008). Like POM, CDOM will 
be comprised of a humic-like hydrophobic fraction and a water-soluble, more polar, 
component. CDOM generally carries a pH-dependent net negative surface charge due to 
ionised carboxylic acid and phenolic groups, and the more polar constituents are more 
abundant at the lower end (< 1 kDa) of the CDOM size range (Yang et al. 2011). 
The ability of surface water CDOM or its humic components, to bind organic 
contaminants has been reported since the 1980s (Chiou et al. 1986; Chiou et al. 1987), 
although to date there have been very few mechanistic studies of this phenomenon for APIs 
and wastewater or soil CDOM (Blackwell et al. 2009). The antibiotic ciprofloxacin was 
reported to partition into humic material CDOM to a much greater extent than into CDOM 
present in treated municipal wastewater (Carmosini and Lee 2009). The mechanism of 
sorption to the humic CDOM was pH-dependent cation exchange. Similar partitioning to the 
polar compound rich wastewater CDOM was not observed because of the relatively high 
alkalinity of the wastewater. For a range of surface waters (river, estuary) the binding of APIs 
to CDOM appeared to be dominated by the larger (> 1 kDa) hydrophobic fractions, although 
the pH dependency of this phenomenon was not explored (Liu et al. 2005; Maskaoui et al. 
2007; Yang et al. 2011). The partitioning of the APIs into the estuarine CDOM was 2–4 
orders of magnitude higher than into (OC–normalised) suspended matter, emphasising the 
importance of CDOM to API binding in surface waters (Yang et al. 2011). It has been 
reported that the character of CDOM (e.g. hydrophobic/hydrophilic balance, molecular 
size/weight distribution) can change during wastewater treatment, and with type of treatment 
(Shon et al. 2006). It is likely, therefore, that the binding and reactivity of an API in untreated 
and treated wastewater may be quite different and perhaps impact on its fate in irrigated soils 
(Gibson et al. 2010). From these findings it would appear that studies of API–wastewater or 
API-soil CDOM interactions should become a focus for research. 
 
2.3.5 Clay – organic matter interactions and API sorption 
While the clay and  soil organic matter constituents have been described separately in 
order to highlight the global variations in their physico-chemical characteristics, in reality 
these moieties exist as intimate, and complex, organo-mineral assemblages as a result of solid 
– solution interactions; indeed, in temperate soils, 50 – 75 % of the soil organic matter is 
assemblage material (Christensen 2001) In the last two decades an arguably realistic 
conceptual model of these assemblages has emerged (Kleber et al. 2007). This zonal model, 
in principle, allows for the chemical bonding mechanisms between APIs and soil components 
(Fig. 4) that are understood to occur (ECETOC, 2013b). These mechanisms include van der 
Waals, hydrogen and covalent bonding, ionic and ligand exchange, charge transfer and 
hydrophobic interactions (Fig. 4). The model also allows for physical sequestration into the 
soil organic matter matrix. Empirical data are beginning to reveal that the assemblages occur 
as discrete clusters and that they are the primary sites for interaction with organic matter in 
soil pore water. Furthermore, most (ca. 80 %) of the clay mineral surface, which has been 
generally perceived as reactive to OM, does not interact with the pore water organic matter at 
all (Vogel et al. 2014). If these findings are corroborated, it may serve to further increase the 
difficulty in predicting API sorption and fate, and subsequent development of ERAs for 
LLMIC soils. 
 
2.4 Environmental risk from APIs in soils of LLMIC 
In Europe, an API is considered to be a risk to the environment and subject to further 
testing when its Log Kow is > 4.5, when the surface water PEC exceeds 0.01 µg L
-1
 (lower for 
compounds with mode of action related concerns), when the surface water PEC:PNEC ratio 
is > 1, or when the surface water PEC:PNEC (microorganism) ratio is > 0.1 (EMEA 2006). 
Confidence in this type of assessment is related to the data available and in some cases 
assumptions are required including worst case scenarios and read across from other 
environmental compartments. For example, EMEA (2006) does not require the calculation of 
soil PECs and PNECs for APIs with a Log KOC <4. The soil PNECs reported in Fig. 8 for a 
range of APIs are predicted from the surface water PNEC using the partition coefficient of 
the API in soil and the bulk density of wet soils (see Table S1), as described in ECB (2002). 
These calculations reveal that measured soil concentrations may be higher than the PNECs 
for fluoxetine, oxytetracycline, triclosan and tetracycline in some cases (Fig. 8). Although 
soil concentrations of APIs in LLMIC are generally low, the dataset is restricted both 
spatially and temporally, as shown in Table 1, and so there is uncertainty regarding risk to 
humans and other biota (Qin et al. 2015). Furthermore, while PNECs are formulated for acute 
toxicity assessments, chronic effects may be more important, particularly as wastewater 
irrigation becomes more widespread. 
 Fig. 8.  Concentrations of selected APIs in global soils with the corresponding 
estimated PNEC in soil. Error bars represent ± standard deviation (n = 3-8). 
(AstraZeneca 2012; Chen et al. 2011; Durán-Alvarez et al. 2009; Gibson et al. 
2010; Jones et al. 2002; Li et al. 2011; Martín et al. 2012; Oakes et al. 2010; 
Rutgersson et al. 2014; Vazquez-Roig et al. 2012; Wu et al. 2010; Zhao et al. 
2010) 
 
Estimates of annual API loading to soils from wastewater irrigation may be obtained 
by using representative irrigation rates and measured concentrations of APIs in irrigation 
waters from LLMIC. While this type of calculation has been performed for  high income 
countries (Qin et al. 2015), it is rare for LLMIC because data on API concentrations in 
irrigation water are not readily measured and/or available. In principle, the resulting 
maximum concentrations in soils can then be calculated, assuming zero losses (i.e. from 
lateral run-off, loss to groundwater, biotransformation) and representative infiltration depths 
and soil densities. Table 2 shows results using this approach for soils in Tula Valley (Mexico), 
where extensive irrigation using untreated wastewater occurs (Gibson et al. 2010). The 
calculated maximum soil API concentrations for naproxen, diclofenac and carbamazepine are 
significantly lower (> order of magnitude) than the predicted no effect concentrations (PNEC) 
for soil of 2357 µg kg
-1
, 735 µg kg
-1
 and 48.6 µg kg
-1
, respectively (PNEC values are 
reported in Table S1). In contrast, the PNECs for ibuprofen and triclosan, of 3.0 µg kg
-1
 and 
3.74 µg kg
-1
, respectively, are within an order of magnitude of the calculated maximum soil 
concentrations. Coupled with data on sorption of APIs to soils and API persistence, this type 
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of analysis is essential for the estimation of predicted environmental concentrations (PECs) of 
APIs, which are central to the development of robust environmental risk assessments. 
Table 2.  API loads to soils in Tula Valley, Mexico, from untreated irrigation 
wastewater and estimated maximum soil concentrations (Gibson et al. 2010) 
 
API API 
concentration  
(µg L
-1
) 
Irrigation 
rate  
(L water 
m
-2
 y
-1
) 
API 
annual 
load  
(µg) 
Infiltration 
depth  
(m) 
Soil 
density  
(kg m
-
3
) 
Soil 
mass 
(kg) 
Max soil API 
concentration  
(µg kg
-1
 DW
a
) 
Naproxen 7.3 300 2190 0.3 1500 450 0.114.87 
Naproxen 13.6 300 4080 0.3 1500 450 9.07 
Ibuprofen 0.74 300 222 0.3 1500 450 0.49 
Ibuprofen 1.41 300 423 0.3 1500 450 0.94 
Diclofenac 2.05 300 615 0.3 1500 450 1.37 
Diclofenac 4.82 300 1446 0.3 1500 450 3.21 
Carbamazepine 0.084 300 25.2 0.3 1500 450 0.06 
Carbamazepine 0.24 300 72 0.3 1500 450 0.16 
Triclosan 0.084 300 25.2 0.3 1500 450 0.06 
Triclosan 1.03 300 309 0.3 1500 450 0.69 
 
a
DW – dry weight of soil 
The toxicity of APIs to non-target organisms will depend on, inter alia, the speciation 
of the compound (i.e. the relative amounts of free and bound chemical and their 
lipophilicities). The amelioration of xenobiotic compound toxicity due to binding with 
polymeric aromatic humic and fulvic acids has been reported since the 1980s (Chiou et al. 
1986, 1987; Oris et al. 1990; Day 1991; Haitzer et al. 1998). For example, fulvic and protein 
rich CDOM in wastewater effluent reduced endocrine disrupting chemical toxicity to biota; 
the most effective CDOM was in the < 0.2 µm size fraction, while CDOM in the < 5 kDa 
fraction did not reduce toxicity of the endocrine disrupting chemical (Lee et al. 2011). The 
influence of CDOM on the speciation, bioavailability and toxicity of metals in surface waters 
is now well established (Aiken et al. 2011). The resulting Biotic Ligand Model of CDOM–
metal interactions represented a major advance in metal toxicity standards and is now 
enshrined in EU and USA environmental quality standards (Comber et al. 2008; Aiken et al. 
2011). Similar toxicity amelioration experiments of wastewater CDOM or soil solids with 
APIs have not been reported (Qin et al. 2015). Following the experience with metals, this is 
an area of study that clearly merits further effort from the scientific and regulatory 
communities. 
In summary, there is a paucity of information on the potential ecotoxicological 
impacts of APIs in the terrestrial environments of LLMIC (Kookana et al. 2014). While 
knowledge transfer from high income countries to LLMICs of API soil biogeochemistry will 
prove of benefit in some instances, basic datasets on API loadings to the environment, 
coupled to more systematic measurements of free and bound APIs in soils and waters, are 
needed so that realistic PECs can be calculated and resultant exposures of biota to 
contaminant pharmaceuticals elucidated.  The development of any subsequent risk 
assessments, equivalent to the Phase II effects testing of EMEA (2006), should use 
appropriate test organisms.  
 
3. Conclusions  
 Water scarcity in LLMICs and the increasing use of APIs globally has led to concerns 
about the input of APIs and other down the drain chemicals to soils during irrigation with 
wastewater, a concern that has now been recognised by the International Conference on 
Chemical Management. Wastewater reuse for irrigation is currently not included in terrestrial 
environmental risk assessments of APIs and terrestrial assessments are only conducted for 
APIs with a Log KOC >4, in Europe or elsewhere. For the development of API risk 
assessment-type frameworks within LLMIC there remains much to do. The datasets missing 
include accurate API usage in LLMICs, estimates of point and diffuse sources of APIs, 
(including removal efficiencies during effluent processing in sewage treatment plants, where 
this occurs), to soils and waters, sludge and irrigation water application rates to land, and the 
speciation and partitioning of the APIs in those compartments. Soil physico-chemical factors 
and the chemical structure and behaviour of APIs will influence their fate in soil. A wide 
range of soil conditions exist in LLMIC globally, making the development of predictive 
models of soil behaviour, distributions and fate of APIs a challenge. For more extensive 
assessments of API behaviour and effects, where required, within an environmental risk 
assessment framework, it is a prerequisite that methods are appropriate. For example, while 
OECD methods 106 and 307 for determining the fate of ionisable chemicals in soils largely 
cover the range of soil properties (pH, clay content, soil organic matter concentration) to be 
found in LLMIC, care must be taken in the selection of soils used for testing to ensure that 
they are representative for the region of interest. 
The development of environmental risk assessments is a resource intensive process. 
However, without robust monitoring in combination with mechanistic fate data for the 
partitioning and degradation of APIs in soils of LLMIC countries, it is not possible to address 
the risk of APIs in the environment. The limited data available for APIs in soil identified here, 
suggests that within LLMIC, regulators, the wastewater treatment industry, the relevant 
pharmaceutical sectors, and other stakeholders should co-operate in the development of 
ERAs in the most cost-effective way.  
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Table S1. API risk assessment data  
API Treatment Area % dose 
excreted 
Aquatic 
PEC 
 (µg L
-1
) 
Aquatic 
PNEC 
(µg L
-1
) 
Aquatic 
PEC/ 
PNEC 
Soil 
PNEC
b
 
(µg kg
-1
) 
pKa Log Koc 
(L kg
-1
) 
Log 
Kow 
Kd soil
b
 
(L kg
-1
) 
Kd 
sewage 
sludge
b
 
(L kg
-1
) 
Water 
solubility 
(g L
-1
) 
Atenolol Cardiovascular  0.68 148 0.0046 1306 9.6 2.6 0.015 7.96 2.95 26.5 
Carbamazepine Neuroscience 1-2
c 
1.23
d 
6.36
d 
0.19
d 
48.6 7
e 
2.56 2.45
i 
5.64 2.09 0.112
i 
Ciprofloxacin Infection 84
c 
0.035
g 
991
g 
0.0035 248915 6.09
g 
3.1
h 
0.28
i 
427
h 
417
h 
30
i 
Diclofenac Neuroscience 15
c 
0.8
d 
138.74
d 
0.0058
d 
735 4.15
j 
2.39
k 
4.51
i 
9
k 
105
k 
0.0024
i 
Fluoxetine Neuroscience 3-11
c 
0.052
l 
0.012
l 
4.3
l 
1.8-4.5 10.06
l 
4.1-4.5
l 
4.26
l 
251.79-
632.46 
4658-
11700 
60.3
l 
Ibuprofen Neuroscience 1-8
c 
4.96
d 
9.06
d 
0.55
d 
3.0 4.91
e 
2.01-
2.11
m 
3.97
i 
0.56-
3.71
m 
37.86-
47.67 
0.021
i 
Naproxen Neuroscience 0-10
n 
 21.2
o 
 2357 4.2
d 
2.48
k 
3.18
i 
11
k 
36
k 
0.016
i 
Norfloxacin Infection 50-68
p
 0.24
q 
40
q 
0.006 47-
12611 
6.30, 
8.38
p 
4.8-5.5
p 
-1.03
q 
2-536
r 
23345.42
-
117004.3 
0.35
p 
Ofloxacin Infection  0.05
g 
3.13
g 
0.02 569 6.05, 
8.51
g 
4.6
h 
-0.39
i 
309
h 
1.7
h 
28.26
i 
Oxytetracycline Infection  0.83
d 
0.23
d 
3.6
d 
0.3 3.3, 
9.1
j 
1.99
d 
-0.9
i 
1.95 36.16 0.313
i 
Propranolol  Cardiovascular 17 0.044 0.1 0.44 3.4 9.53 3.21
k 
-0.12-
2.6 
58
k 
600.07 97.9 
Salicylic acid Dermis  1.04
q 
43.1
o 
0.02 2079
 
 3.35
k 
2.26 82
k 
23
k 
2.24
i 
Sulfamethoxazole Infection 15
c 
0.016
g 
0.21
g 
0.08 0.99 6
g 
2.34
k 
0.89
i 
8
k 
11
k 
0.61
i 
Triclosan Infection   0.05
r 
 3.74 7.8
e 
3.54
k 
4.8
e 
127
k 
1283
k 
0.005
i 
a
 Data with no citation are from AstraZeneca Environmental Risk Assessment Data (AstraZeneca 2012). 
b 
Soil PNEC, Kd soil and Kd sewage 
sludge were predicted using the TGD method unless stated otherwise (ECB 2002). 
c 
(Jjemba 2006). 
d
 (Jones et al. 2002). 
e 
(Azzouz and 
Ballesteros 2012). 
f 
(Vazquez-Roig et al. 2012). 
g
 (NCCOS 2006). 
h 
(Thiele-Bruhn 2003).
i
 (Chen et al. 2011). 
j
 (Berthod et al. 2014). 
k
 (Barron et 
al. 2009). 
l
 (Oakes et al. 2010). 
m
 (Xu et al. 2009). 
n
 (Carballa et al. 2008). 
o
 (Martín et al. 2012). 
p
 (Peruchi et al. 2015). 
q
 (Perazzolo et al. 2010). 
r
 (Chen and Zhou 2014).
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Figure S1. Municipal wastewater production (10
9 
m
3
a
-1
) (FAO/IIASA/ISRIC/ISS-CAS/JRC 
2009) 
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Figure S2. Water withdrawal by agriculture relative to other economic sectors (%) 
(FAO/IIASA/ISRIC/ISS-CAS/JRC 2009) 
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Figure S3. Spending (Billion US dollars) on human medicines in pharmerging countries to 
2018. Tier 3 countries include Algeria, Argentina, Colombia, Egypt, Indonesia, Mexico, 
Nigeria, Pakistan, Poland, Romania, Saudi Arabia, South Africa, Thailand, Turkey, Ukraine, 
Venezuela, Vietnam (IMS Institute for Healthcare Informatics 2014). 
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Figure S4. Percentage of acidic or basic API in ionised form as pH varies from less than 4 
units to greater than 4 units from the compound pKa (ECETOC 2013).
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